https://click.mail.23andme.com/?qs=f853fc4808ead70686fd4dd573c2d8fb53d37490831fef4571d7c3d77e311c2b6738b05943a0fb96767230429fa9d2cb9fed65c9953d1834 Dear Sam, Since the inception of 23andMe, our mission has been to help people access, understand and benefit from the human genome. We have spent the last decade focused on enabling people to get access to their genome and understand what it means. We have also built a significant research team that has published over 100 scientific papers. In 2015, we launched 23andMe Therapeutics to develop novel treatments and cures based on genetic insights from the consented 23andMe community. Today, I am thrilled to announce that we are launching a collaboration with GlaxoSmithKline (GSK) to accelerate our ability to make those novel treatments and cures a reality. I hear regularly from customers, like you, that they want to be part of a solution that is improving health care. We all have some disease or health issue that we care about. 23andMe has created a research platform to enable interested customers to participate in research - to not wait for solutions to appear, but for people to come together and make discoveries happen. By working with GSK, we believe we will accelerate the development of breakthroughs. Our genetic research - powered by millions of customers who have agreed to contribute - combined with GSK's expertise in drug discovery and development, gives us the best chance for success. Our top priority is you, the customer, and empowering you with the options to participate in research. As always, you choose whether or not to participate in research. You can choose to https://click.mail.23andme.com/?qs=f853fc4808ead706b011a3dd820813a75572dbbbb2485833279ec547c4dffcedfc68b79f9b53b00d744c35c8691e3329f2b3608cf9941280 opt-in or opt-out at any time. I started 23andMe with the belief that by getting people interested in learning about themselves and participating in research, we would all benefit. Today is an important milestone in how 23andMe will be able to impact the lives of those with disease and how we will be able to improve the future of healthcare. Anne You are receiving this email because you are a customer of 23andMe.(c) 2007-2018 23andMe, Inc.23andMe, Inc., 899 W. Evelyn Avenue, Mountain View, CA 94041, USA https://click.mail.23andme.com/?qs=f853fc4808ead70634ef70bc168a134007724080addf67f4adf5ad838b5aed054c4c583637e9537777565c349f3b74f9fad3272a488430c5 update your 23andMe email preferences | https://click.mail.23andme.com/unsub_center.aspx?qs=1890449f0bb25765a87d3bc0564352041d9b58c0c42e947cf9acf90f4a43cd74a6e8ace2d0d7e6ba4958bdc889d5f1bffc7c12ba13ab13dd82f2ba7a94c33dd179743a5537076b41a676079ec74f26bf unsubscribe from 23andMe emails